Tag Archives: encorafenib

June, 2018

September, 2017

January, 2015

  • 26 January

    Array BioPharma Gains Rights to Novartis’ Cancer Candidate

    BioPharma has struck a deal with Novartis Pharma AG for rights to an investigational cancer drug. Array recently announced that it has entered into a definitive agreement with Novartis to acquire worldwide rights to encorafenib (LGX818), Novartis’ BRAF inhibitor in development for treatment of skin and colorectal cancer. The deal …